Search Button
All News

Subject:Omega 3 protects against diabetic retinopathy, study finds

Omega 3 protects against diabetic retinopathy, study finds

Ophthalmos Institute has a patent in Europe and USA (April 2016) for treating diabetic retinopathy with omega 3 fatty acids when current therapies fail. The dose depends on a blood test, so that the AA/EPA ratio is within Ophthalmos therapeutic range. A recent study confirms the effect of Ophthalmos treatment for patients with diabetes and eye disease.

Aleix Sala-Vila, D.Pharm., Ph.D., of the Lipid Clinic, Barcelona, and colleagues conducted a prospective study within the randomized clinical trial Prevencion con Dieta Mediterranea (PREDIMED), testing Mediterranean diets supplemented with extra virgin olive oil or nuts vs a control diet for primary cardiovascular prevention. The trial was conducted in primary health care centers in Spain. From 2003 to 2009, 3,614 individuals age 55 to 80 years with a previous diagnosis of type 2 diabetes were recruited. Full data were available for 3,482 participants (48 percent men; average age 67 years). 

Of the participants, a total of 2,611 (75 percent) met the target LCω3PUFA recommendation. During a median follow-up of 6 years, incident DR was diagnosed in 69 of the study participants. After adjusting for age, sex, intervention group, and lifestyle and clinical variables, participants meeting the LCω3PUFA recommendation at baseline (500 mg/d or greater) compared with those not fulfilling this recommendation (less than 500 mg/d) showed a 48 percent relatively reduced risk of incident sight-threatening DR.

Journal References:

Emilio Ros, MD, PhD et al. Dietary Marine ω-3 Fatty Acids and Incident Sight-Threatening Retinopathy in Middle-Aged and Older Individuals With Type 2 Diabetes: Prospective Investigation From the PREDIMED Trial. JAMA Ophthalmol., August 2016 DOI:

Contact Us

Ophthalmos Research & Educational Institute
Morfou 48, Egkomi
2417 Nicosia, Cyprus
Tel.: +357 22 464 344
Fax: +357 22 464 345

Contact our department

Copyright (C) 2017, Ophthalmos   |    Designed and Developed by eBOS Technologies   |    powered by WiseBOS CMS